secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001628280-24-046293
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp Q3 net loss $3.2M; guides down system-wide sales and new openings
----------------------------------------------------------------------------

- Revenue $30.2M (+2% YoY); net loss $3.2M vs $716K loss in Q3 2023, including $3.8M impairment.
- Adjusted EBITDA fell to $2.4M from $2.9M; system-wide sales up 18% to $129.3M.
- Guidance cut: system-wide sales now $525-535M (prior $530-545M); new franchised openings 55-60 (prior 60-75).
- Total clinics 963 at Sept 30; sold 7 franchise licenses in Q3 vs 12 in Q3 2023.
- Unrestricted cash $20.7M; $20M credit facility available through Feb 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000162828024046293/0001628280-24-046293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000162828024046293/jynt-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-046293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer